CAS 328-90-5
:Acido 2-idrossi-4-(trifluorometil)benzoico
- 2,4-Cresotic acid, α,α,α-trifluoro-
- 2-Hydroxy-4-(Trifluoromethyl)Benzoic Acid
- 2-Hydroxy-4-Trifluoromethylbenzoic Acid
- 4-(Trifluoromethy)Salicylic Acid
- 4-(Trifluoromethyl)-2-Hydroxybenzoic Acid
- 4-Trifluoromethyl Salicylic Acid
- 4-Trifluoromethylsalicylic Acid
- 4-Trifluoromethylsalicylicacid
- Benzoic Acid, 2-Hydroxy-4-(Trifluoromethyl)-
- P-Trifluoromethylsalicylicacid
- Rarechem Al Be 1424
- Trifluoromethylsalicylicacid
- p-(Trifluoromethyl)salicylic acid
- Vedi altri sinonimi
4-(Trifluoromethyl)salicylic Acid
CAS:Formula:C8H5F3O3Purezza:>98.0%(GC)(T)Colore e forma:White to Almost white powder to crystalPeso molecolare:206.124-Trifluoromethylsalicylic acid
CAS:Formula:C8H5F3O3Purezza:97%Colore e forma:SolidPeso molecolare:206.1187Triflusal EP Impurity B
CAS:Prodotto controllatoFormula:C8H5F3O3Colore e forma:NeatPeso molecolare:206.122-Hydroxy-4-(trifluoromethyl)benzoic acid
CAS:2-Hydroxy-4-(trifluoromethyl)benzoic acidFormula:C8H5F3O3Purezza:98%Colore e forma: white powderPeso molecolare:206.12g/molTriflusal EP Impurity B-d3 (Desacetyl Triflusalic Acid-d3)
CAS:Formula:C8H2F3O3D3Peso molecolare:209.14Ref: 4Z-T-664
5mgPrezzo su richiesta10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiestaDesacetyl Triflusal
CAS:Applications The active metabolite of Triflusal; inhibits cardiac hypertrophy in vitro and in vivo by blocking the NF-κB signaling pathway.
References Bayon, Y., et al.: Br. J. Pharmacol., 126, 1359 (1999), Cabrero, A., et al.: Diabetes, 50, 1883 (2001), Cabrero, A., et al.: J. Biol. Chem., 277, 10100 (2002), Culebras, A., et al.: Neurology, 62, 1073 (2004),Formula:C8H5F3O3Colore e forma:NeatPeso molecolare:206.124-(Trifluoromethyl)salicylic acid
CAS:Formula:C8H5F3O3Purezza:97%Colore e forma:SolidPeso molecolare:206.12Ref: ST-EA-CP-T186002
10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiestaDesacetyl triflusal
CAS:Triflusal is a drug that inhibits the production of colony-stimulating factor and energy metabolism. It has been shown to have beneficial effects on the liver in vivo. Triflusal also has a chemoattractant protein activity that may be useful for tumor therapy. The pharmacological treatment of triflusal is associated with an increased risk of cancer in humans, which can be attributed to its irreversible inhibition of cyclin D2. Triflusal may have therapeutic potential for treating pain and inflammation, but its use should be limited to patients at low risk for cancer.
Formula:C8H5F3O3Purezza:Min. 95%Colore e forma:PowderPeso molecolare:206.12 g/molRef: 3D-FD21130
Prodotto fuori produzione








